Form 4: Guided Therapeutics Director Acquires Shares Through Dividend Conversion

Director John E. Imhoff acquired 48,327 shares of Guided Therapeutics Inc. common stock through the conversion of accrued dividends on Series D preferred stock.

Summary

• On July 15, 2024, John E. Imhoff, a director and 10% owner of Guided Therapeutics Inc. (GTHP), acquired 48,327 shares of common stock.
• The acquisition was a result of converting accrued dividends on Series D preferred stock at a conversion price of $0.1164 per share.
• Following the transaction, Imhoff beneficially owns 5,226,223 shares of Guided Therapeutics Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in the company's stock. This transaction reflects the conversion of preferred stock dividends into common stock, a common financial mechanism.

Stakeholder Impact

• The transaction increases the number of outstanding common shares, which could have a minor dilutive effect on existing shareholders.

Key Dates

Keywords

Form 4, Beneficial Ownership, Director, Guided Therapeutics Inc, GTHP, John E. Imhoff, Dividend Conversion, Series D Preferred Stock, Common Stock